Osimertinib regressed an EGFR-mutant lung-adenocarcinoma bone-metastasis mouse model and increased long-term survival-Reference-Cited by-同舟云学术

Osimertinib regressed an EGFR-mutant lung-adenocarcinoma bone-metastasis mouse model and increased long-term survival

Published:2020-10 Issue:10 Volume:13 Page:100826
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Higuchi Takashi,Sugisawa Norihiko,Park Jun Ho,Sun Yu,Zhu Guangwei,Yamamoto Norio,Hayashi Katsuhiro,Kimura Hiroaki,Miwa Shinji,Igarashi Kentaro,Bouvet Michael,Singh Shree Ram,Tsuchiya Hiroyuki,Hoffman Robert M.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference19 articles.

1. Clinical analysis of patients with skeletal metastasis of lung cancer;Cho;BMC Cancer,2019

2. Natural history of non-small-cell lung cancer with bone metastases;Santini;Sci. Rep.,2015

3. Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies;D'Antonio;Ther Adv Med Oncol.,2014

4. Prognostic factors in patients with skeletal-related events at non-small-cell lung cancer diagnosis;Tominaga;Mol Clin Oncol.,2017

5. The incidence of EGFR-activating mutations in bone metastases of lung adenocarcinoma;Krawczyk;Pathol. Oncol. Res.,2014

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-molecule targeted therapy shrinks lung lesions and improves bone metastases: A case report;Medicine;2024-07-19

2. From Tumor to Bone: Growth Factor Receptors as Key Players in Cancer Metastasis;Frontiers in Bioscience-Landmark;2024-05-13

3. Assessing EGFR‐mutated NSCLC with bone metastasis: Clinical features and optimal treatment strategy;Cancer Medicine;2024-03-29

4. Femoral bone metastasis is a poor prognostic factor in osimertinib-treated patients with EGFR-mutated non-small cell lung cancer: a retrospective, multicenter study;2024-02-15

5. Femoral bone metastasis is a poor prognostic factor in osimertinib-treated patients with EGFR-mutated non-small cell lung cancer;2023-09-15